Equities

Windlas Biotech Ltd

WINDLAS:NSI

Windlas Biotech Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)879.45
  • Today's Change20.45 / 2.38%
  • Shares traded61.32k
  • 1 Year change+149.84%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue6,3105,1314,659
OPERATING EXPENSES
Cost of revenue total4,1233,3843,138
Selling, general and admin. expenses, total1,3001,037911
Depreciation/amortization134124121
Unusual expense(income)00.080
Other operating expenses, total261921
Total operating expense5,6624,6524,257
Operating income647479403
Other, net3.724.19(0.49)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes771570456
Provision for income taxes18914475
Net income after taxes582426381
Minority interest000
Net income before extra. Items582426381
Total extraordinary items------
Net income582426381
Inc.avail. to common excl. extra. Items582426381
Inc.avail. to common incl. extra. Items582426381
EPS RECONCILIATION
Basic/primary weighted average shares212220
Basic/primary eps excl. extra items282019
Basic/primary eps incl. extra items282019
Dilution adjustment------
Diluted weighted average shares212220
Diluted eps excl. extra items282019
Diluted eps incl. extra items282019
COMMON STOCK DIVIDENDS
DPS - common stock primary issue5.504.003.50
Gross dividend - common stock1148376
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental117.7213
SUPPLEMENTAL INCOME
Depreciation, supplemental132122119
Total special items(0.06)(8.68)(0.1)
NORMALISED INCOME
Normalized income before taxes771562456
Effect of special items on income taxes(0.01)(2.19)(0.02)
Income tax excluding impact of special items18914275
Normalized income after tax582420381
Normalized income avail. to common582420381
Basic normalized EPS281919
Diluted normalized EPS281919
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.